Literature DB >> 7969684

Interstitial nephritis associated with 5-aminosalicylic acid.

T Witte1, C J Olbricht, K M Koch.   

Abstract

A patient with severe Crohn's disease was treated with 5-aminosalicylic acid (5-ASA). Following initiation of treatment, serum creatinine increased slowly from 105 to 530 mumol/l (creatinine clearance 16 ml/min). The diagnosis of an interstitial nephritis was made based on normal urinary findings and the renal biopsy histology of interstitial mononuclear infiltrates and normal glomeruli, 5-ASA was discontinued and serum creatinine decreased to 245 mumol/l (creatinine clearance 40 ml/min) during the following 3 months. Partial reversibility of renal failure following discontinuation of 5-ASA and the absence of other drugs possibly causing interstitial nephritis suggest a causal relationship between 5-ASA and interstitial nephritis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969684     DOI: 10.1159/000188024

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  11 in total

1.  Chronic tubulointerstitial nephritis induced by 5-aminosalicylate in an ulcerative colitis patient: a rare but serious adverse event.

Authors:  Pedro Magalhães-Costa; Leopoldo Matos; Cristina Chagas
Journal:  BMJ Case Rep       Date:  2015-05-02

2.  Late onset interstitial nephritis associated with mesalazine treatment.

Authors:  J Popoola; A F Muller; L Pollock; P O'Donnell; P Carmichael; P Stevens
Journal:  BMJ       Date:  1998-09-19

Review 3.  Hypersensitivity to 5-ASA suppositories.

Authors:  M L Borum; A Ginsberg
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

4.  Role of tumor necrosis factor inhibitor in granulomatous interstitial nephritis secondary to Crohn's disease.

Authors:  Manish K Saha; Hamieh Tarek; Vishal Sagar; Paul Abraham
Journal:  Int Urol Nephrol       Date:  2012-12-30       Impact factor: 2.370

5.  Inflammatory Bowel Diseases Are Associated With an Increased Risk for Chronic Kidney Disease, Which Decreases With Age.

Authors:  Ravy K Vajravelu; Lawrence Copelovitch; Mark T Osterman; Frank I Scott; Ronac Mamtani; James D Lewis; Michelle R Denburg
Journal:  Clin Gastroenterol Hepatol       Date:  2019-11-01       Impact factor: 11.382

6.  Vedolizumab-Induced Acute Interstitial Nephritis in Ulcerative Colitis.

Authors:  Deloshaan Subhaharan; Pradeep K Ramaswamy; Sewwandi Francisco; Naveed Ishaq
Journal:  ACG Case Rep J       Date:  2022-06-24

7.  Interstitial nephritis from mesalazine: case report and literature review.

Authors:  Lois J Arend; James E Springate
Journal:  Pediatr Nephrol       Date:  2004-03-09       Impact factor: 3.714

8.  Renal effects of long-term treatment with 5-aminosalicylic acid.

Authors:  H Patel; A Barr; K N Jeejeebhoy
Journal:  Can J Gastroenterol       Date:  2009-03       Impact factor: 3.522

9.  The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease.

Authors:  Josephine M Ambruzs; Patrick D Walker; Christopher P Larsen
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-21       Impact factor: 8.237

10.  No dose-dependent tubulotoxicity of 5-aminosalicylic acid: a prospective study in patients with inflammatory bowel diseases.

Authors:  Carsten Dehmer; Roland Greinwald; Juergen Löffler; Wolfgang Grotz; Lothar Wolf; Hans-Burkhardt Hagmann; Werner Schneider; Wolfgang Kreisel
Journal:  Int J Colorectal Dis       Date:  2003-02-08       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.